Asim, O and Petrou, S (2005). Valuing a QALY: review of current controversies Expert Review of Pharmacoeconomics and Outcomes Research, 5(6):667-669.

Briggs, A (2005). Probabilistic analysis of cost-effectiveness models: statistical representation of parameter uncertainty. Value Health, 8(1):1-2.

Briggs, A, Nixon, R, Dixon, S, and Thompson, S (2005). Parametric modelling of cost data: some simulation evidence. Health Econ, 14(4):421-8.

Campbell, HE, Tait, S, Sharples, LD, Caine, N, Gray, TJ, Schofield, PM, and Buxton, MJ (2005). Trial-based cost-utility comparison of percutaneous myocardial laser revascularisation and continued medical therapy for treatment of refractory angina pectoris. Eur J Health Econ, 6(4):288-97.

Clarke, PM, Gray, AM, Briggs, A, Stevens, RJ, Matthews, DR, and Holman, RR (2005). Cost-utility analyses of intensive blood glucose and tight blood pressure control in type 2 diabetes (UKPDS 72). Diabetologia, 48(5):868-77.

Claxton, K, Sculpher, M, McCabe, C, Briggs, A, Akehurst, R, Buxton, M, Brazier, J, and O'Hagan, T (2005). Probabilistic sensitivity analysis for NICE technology assessment: not an optional extra. Health Econ, 14(4):339-47.

Edwards, SJ, Emmas, CE, and Campbell, HE (2005). Systematic review comparing meropenem with imipenem plus cilastatin in the treatment of severe infections. Curr Med Res Opin, 21(5):785-94.

Fraser, WD, Hofmeyr, J, Lede, R, Faron, G, Alexander, S, Goffinet, F, Ohlsson, A, Goulet, C, Turcot-Lemay, L, Prendiville, W, Marcoux, S, Laperriere, L, Roy, C, Petrou, S, Xu, H, and Wei, B (2005). Amnioinfusion for the prevention of the meconium aspiration syndrome. N Engl J Med, 353(9):909-17.

Frew, EJ, Wolstenholme, JL, and Whynes, DK (2005). Eliciting relative preferences for two methods of colorectal cancer screening. Eur J Cancer Care (Engl), 14(2):124-31.

Gagnon, YM, Levy, AR, Spencer, MD, Hurley, JS, Frost, FJ, Mapel, DW, and Briggs, AH (2005). Economic evaluation of treating chronic obstructive pulmonary disease with inhaled corticosteroids and long-acting beta2-agonists in a health maintenance organization. Respir Med, 99(12):1534-45.

Gardner, F, Dezateux, C, Elbourne, D, Gray, A, King, A, and Quinn, A (2005). The hip trial: psychosocial consequences for mothers of using ultrasound to manage infants with developmental hip dysplasia. Arch Dis Child Fetal Neonatal Ed, 90(1):F17-24.

Gonzalez-Perez, JG, Vale, L, Stearns, SC, and Wordsworth, S (2005). Hemodialysis for end-stage renal disease: a cost-effectiveness analysis of treatment-options. Int J Technol Assess Health Care, 21(1):32-9.

Gray, A (2005). Population Ageing and Healthcare Expenditure Ageing Horizons, 2005(2):15-20.

Gray, A (2005). Adverse events and the National Health Service: an economic perspective. A report to the National Patient Safety Agency.

Gray, A, Elbourne, D, Dezateux, C, King, A, Quinn, A, and Gardner, F (2005). Economic evaluation of ultrasonography in the diagnosis and management of developmental hip dysplasia in the United Kingdom and Ireland. J Bone Joint Surg Am, 87(11):2472-9.

Gray, AM (2005). Cancer funding throughout the world: an economist's perspective. Lancet Oncology:456-457.

Kendrick, T, Simons, L, Mynors-Wallis, L, Gray, A, Lathlean, J, Pickering, R, Harris, S, Rivero-Arias, O, Gerard, K, and Thompson, C (2005). A trial of problem-solving by community mental health nurses for anxiety, depression and life difficulties among general practice patients. The CPN-GP study. Health Technol Assess, 9(37):1-104, iii.

Kortt, M and Clarke, P (2005). Estimating utility values for health states of overweight and obese individuals using the SF-36. Quality of Life Research, 14(10):2177-85.

Leal, J, Luengo-Fernandez, R, and Gray, A (2005). Economic Costs. In: Petersen S, Rayner M, Peto V et al (eds.) European Cardiovascular Disease Statistics.British Heart Foundation. Booklet, Booklet.

Legood, R and McInnes, E (2005). Pressure ulcers: guideline development and economic modelling. J Adv Nurs, 50(3):307-14.